{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:16:08Z","timestamp":1788304568629,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":28,"publisher":"Springer US","isbn-type":[{"value":"9781071653753","type":"print"},{"value":"9781071653760","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5376-0_4","type":"book-chapter","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:41:24Z","timestamp":1788302484000},"page":"69-89","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Generation and Use of an Alloantigen-Specific Preclinical Humanized Mouse Model of Fetal and Neonatal Alloimmune Thrombocytopenia"],"prefix":"10.1007","author":[{"given":"Huiying","family":"Zhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra K.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"5","key":"4_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/bjh.13639","volume":"171","author":"BR Curtis","year":"2015","unstructured":"Curtis BR (2015) Recent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia. Br J Haematol 171(5):671\u2013682. https:\/\/doi.org\/10.1111\/bjh.13639","journal-title":"Br J Haematol"},{"issue":"2","key":"4_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/anc.0000000000000775","volume":"21","author":"T Norton","year":"2021","unstructured":"Norton T, Newberry D, Jnah A (2021) Neonatal alloimmune thrombocytopenia: a concise review. Adv Neonatal Care 21(2):115\u2013121. https:\/\/doi.org\/10.1097\/anc.0000000000000775","journal-title":"Adv Neonatal Care"},{"issue":"2","key":"4_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ajog.2021.04.211","volume":"225","author":"JB Bussel","year":"2021","unstructured":"Bussel JB, Vander Haar EL, Berkowitz RL (2021) New developments in fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 225(2):120\u2013127. https:\/\/doi.org\/10.1016\/j.ajog.2021.04.211","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"4_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.blre.2007.09.002","volume":"22","author":"JB Bussel","year":"2008","unstructured":"Bussel JB, Primiani A (2008) Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates. Blood Rev 22(1):33\u201352. https:\/\/doi.org\/10.1016\/j.blre.2007.09.002","journal-title":"Blood Rev"},{"issue":"3","key":"4_CR5","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1182\/blood-2006-08-040121","volume":"110","author":"J Kjeldsen-Kragh","year":"2007","unstructured":"Kjeldsen-Kragh J et al (2007) A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood 110(3):833\u2013839. https:\/\/doi.org\/10.1182\/blood-2006-08-040121","journal-title":"Blood"},{"issue":"7","key":"4_CR6","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1182\/blood.V92.7.2280","volume":"92","author":"LM Williamson","year":"1998","unstructured":"Williamson LM et al (1998) The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 92(7):2280\u20132287","journal-title":"Blood"},{"issue":"1","key":"4_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2019.102704","volume":"59","author":"TW de Vos","year":"2020","unstructured":"de Vos TW et al (2020) Epidemiology and management of fetal and neonatal alloimmune thrombocytopenia. Transfus Apher Sci 59(1):102704. https:\/\/doi.org\/10.1016\/j.transci.2019.102704","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"4_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00404-020-05618-y","volume":"302","author":"S Wienzek-Lischka","year":"2020","unstructured":"Wienzek-Lischka S et al (2020) Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events. Arch Gynecol Obstet 302(2):355\u2013363. https:\/\/doi.org\/10.1007\/s00404-020-05618-y","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"4_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2019.102710","volume":"59","author":"H Wabnitz","year":"2020","unstructured":"Wabnitz H, Khan R, Lazarus AH (2020) The use of IVIg in fetal and neonatal alloimmune thrombocytopenia- principles and mechanisms. Transfus Apher Sci 59(1):102710. https:\/\/doi.org\/10.1016\/j.transci.2019.102710","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"4_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bjh.12235","volume":"161","author":"JA Peterson","year":"2013","unstructured":"Peterson JA, JG MF, Curtis BR, Aster RH (2013) Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management. Br J Haematol 161(1):3\u201314. https:\/\/doi.org\/10.1111\/bjh.12235","journal-title":"Br J Haematol"},{"issue":"5","key":"4_CR11","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1172\/jci114082","volume":"83","author":"PJ Newman","year":"1989","unstructured":"Newman PJ, Derbes RS, Aster RH (1989) The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33\/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 83(5):1778\u20131781. https:\/\/doi.org\/10.1172\/jci114082","journal-title":"J Clin Invest"},{"issue":"2","key":"4_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0198-8859(92)90036-m","volume":"34","author":"D L'Abb\u00e9","year":"1992","unstructured":"L'Abb\u00e9 D et al (1992) Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1*0201. Hum Immunol 34(2):107\u2013114. https:\/\/doi.org\/10.1016\/0198-8859(92)90036-m","journal-title":"Hum Immunol"},{"issue":"2","key":"4_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0198-8859(90)90104-W","volume":"27","author":"N Valentin","year":"1990","unstructured":"Valentin N et al (1990) HLA-DRw52a is involved in alloimmunization against PL-A1 antigen. Hum Immunol 27(2):73\u201379. https:\/\/doi.org\/10.1016\/0198-8859(90)90104-W","journal-title":"Hum Immunol"},{"issue":"1","key":"4_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2019.102707","volume":"59","author":"J Kjeldsen-Kragh","year":"2020","unstructured":"Kjeldsen-Kragh J, Ahlen MT (2020) Foetal and neonatal alloimmune thrombocytopenia\u2014the role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal\/neonatal outcome. Transfus Apher Sci 59(1):102707. https:\/\/doi.org\/10.1016\/j.transci.2019.102707","journal-title":"Transfus Apher Sci"},{"issue":"10","key":"4_CR15","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.humimm.2013.06.025","volume":"74","author":"L Gragert","year":"2013","unstructured":"Gragert L, Madbouly A, Freeman J, Maiers M (2013) Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry. Hum Immunol 74(10):1313\u20131320. https:\/\/doi.org\/10.1016\/j.humimm.2013.06.025","journal-title":"Hum Immunol"},{"issue":"4","key":"4_CR16","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/trf.15152","volume":"59","author":"J Kjeldsen-Kragh","year":"2019","unstructured":"Kjeldsen-Kragh J, Olsen KJ (2019) Risk of HPA-1a-immunization in HPA-1a-negative women after giving birth to an HPA-1a-positive child. Transfusion 59(4):1344\u20131352. https:\/\/doi.org\/10.1111\/trf.15152","journal-title":"Transfusion"},{"issue":"7","key":"4_CR17","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1182\/blood-2005-06-2562","volume":"107","author":"H Ni","year":"2006","unstructured":"Ni H et al (2006) A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy. Blood 107(7):2976\u20132983. https:\/\/doi.org\/10.1182\/blood-2005-06-2562","journal-title":"Blood"},{"issue":"18","key":"4_CR18","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1182\/blood-2010-05-284919","volume":"116","author":"P Chen","year":"2010","unstructured":"Chen P et al (2010) Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy. Blood 116(18):3660\u20133668. https:\/\/doi.org\/10.1182\/blood-2010-05-284919","journal-title":"Blood"},{"issue":"2","key":"4_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1537-2995.2008.01972.x","volume":"49","author":"T Bakchoul","year":"2009","unstructured":"Bakchoul T et al (2009) Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia. Transfusion 49(2):265\u2013270. https:\/\/doi.org\/10.1111\/j.1537-2995.2008.01972.x","journal-title":"Transfusion"},{"issue":"3","key":"4_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1182\/blood-2013-02-481887","volume":"122","author":"C Ghevaert","year":"2013","unstructured":"Ghevaert C et al (2013) Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers. Blood 122(3):313\u2013320. https:\/\/doi.org\/10.1182\/blood-2013-02-481887","journal-title":"Blood"},{"issue":"9","key":"4_CR21","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1182\/blood.V93.9.2959.409k20_2959_2967","volume":"93","author":"EA Barron-Casella","year":"1999","unstructured":"Barron-Casella EA et al (1999) Construction of a human platelet alloantigen-1a epitope(s) within murine glycoprotein IIIa: identification of residues critical to the conformation of the antibody binding site(s). Blood 93(9):2959\u20132967","journal-title":"Blood"},{"issue":"21","key":"4_CR22","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1182\/bloodadvances.2018023341","volume":"2","author":"H Zhi","year":"2018","unstructured":"Zhi H et al (2018) High-resolution mapping of the polyclonal immune response to the human platelet alloantigen HPA-1a (Pl(A1)). Blood Adv 2(21):3001\u20133011. https:\/\/doi.org\/10.1182\/bloodadvances.2018023341","journal-title":"Blood Adv"},{"issue":"18","key":"4_CR23","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1182\/bloodadvances.2021004371","volume":"5","author":"H Zhi","year":"2021","unstructured":"Zhi H et al (2021) Preclinical evaluation of immunotherapeutic regimens for fetal\/neonatal alloimmune thrombocytopenia. Blood Adv 5(18):3552\u20133562. https:\/\/doi.org\/10.1182\/bloodadvances.2021004371","journal-title":"Blood Adv"},{"issue":"20","key":"4_CR24","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1182\/blood.2022015666","volume":"140","author":"H Zhi","year":"2022","unstructured":"Zhi H, Sheridan D, Newman DK, Newman PJ (2022) Prophylactic administration of HPA-1a-specific antibodies prevents fetal\/neonatal alloimmune thrombocytopenia in mice. Blood 140(20):2146\u20132153. https:\/\/doi.org\/10.1182\/blood.2022015666","journal-title":"Blood"},{"issue":"1","key":"4_CR25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4049\/immunohorizons.2100097","volume":"6","author":"TV M\u00f8rtberg","year":"2022","unstructured":"M\u00f8rtberg TV et al (2022) Prevention of fetal\/neonatal alloimmune thrombocytopenia in mice: biochemical and cell biological characterization of isoforms of a human monoclonal antibody. Immunohorizons 6(1):90\u2013103. https:\/\/doi.org\/10.4049\/immunohorizons.2100097","journal-title":"Immunohorizons"},{"issue":"11","key":"4_CR26","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA et al (2013) Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8(11):2281\u20132308. https:\/\/doi.org\/10.1038\/nprot.2013.143","journal-title":"Nat Protoc"},{"key":"4_CR27","doi-asserted-by":"publisher","unstructured":"Cho A, Haruyama N, Kulkarni AB (2009) Generation of transgenic mice. Curr Protoc Cell Biol. Chapter 19:Unit 19.11. https:\/\/doi.org\/10.1002\/0471143030.cb1911s42","DOI":"10.1002\/0471143030.cb1911s42"},{"issue":"11","key":"4_CR28","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1111\/j.1537-2995.2004.04197.x","volume":"44","author":"E Sayeh","year":"2004","unstructured":"Sayeh E et al (2004) Immune responsiveness against allogeneic platelet transfusions is determined by the recipient's major histocompatibility complex class II phenotype. Transfusion 44(11):1572\u20131578. https:\/\/doi.org\/10.1111\/j.1537-2995.2004.04197.x","journal-title":"Transfusion"}],"container-title":["Methods in Molecular Biology","Methods in Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5376-0_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:41:25Z","timestamp":1788302485000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5376-0_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071653753","9781071653760"],"references-count":28,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5376-0_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}